The extent of liver injury determines hepatocyte fate toward senescence or cancer
It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury det...
Gespeichert in:
Veröffentlicht in: | Cell death & disease 2018-05, Vol.9 (5), p.575-14, Article 575 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 14 |
---|---|
container_issue | 5 |
container_start_page | 575 |
container_title | Cell death & disease |
container_volume | 9 |
creator | Wang, Chao Chen, Wen-Jian Wu, Ying-Fu You, Pu Zheng, Shang-Yong Liu, Chang-Cheng Xiang, Dao Wang, Min-Jun Cai, Yong-Chao Zhao, Qing-Hui Borjigin, Uyunbilig Liu, Wei Xiong, Wu-Jun Wangensteen, Kirk J. Wang, Xin Liu, Zhong-Min He, Zhi-Ying |
description | It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC. |
doi_str_mv | 10.1038/s41419-018-0622-x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5951829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2054147526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-716947cb7cc7e31135218647bb0f43959bc55016aa332e9e007855532da163e3</originalsourceid><addsrcrecordid>eNp1kU9rGzEQxUVJSEKSD5BLEfTSyzb6v6tLoYQmLQRKwXehlWftNeuVI2lT-9t3glMnKUQHaeD95mmGR8gVZ184k811VlxxWzHeVMwIUW0_kDPBFK9U09ijV_Upucx5xfBIyYQ2J-RU2NqgBz8jv2dLoLAtMBYaOzr0j5BoP66mtKNzKJDW_QiZLmHjSwy7ArTzeJX4x6c5zYBigDEAjYkGj0W6IMedHzJcPr_nZHb7fXbzo7r_dffz5tt9FRRjpaq5saoObR1CDZJzqQVvjKrblnVKWm3boDXjxnspBVhgrG601lLMPTcS5Dn5urfdTO0a5jhESX5wm9Svfdq56Hv3Vhn7pVvER6et5o2waPD52SDFhwlycesedxkGP0KcshNMWmGNajSin_5DV3FKI26HlMYcai0MUnxPhRRzTtAdhuHMPUXm9pE5jMw9Rea22PPx9RaHjn8BISD2QEZpXEB6-fp917_A0KGC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2054147526</pqid></control><display><type>article</type><title>The extent of liver injury determines hepatocyte fate toward senescence or cancer</title><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Wang, Chao ; Chen, Wen-Jian ; Wu, Ying-Fu ; You, Pu ; Zheng, Shang-Yong ; Liu, Chang-Cheng ; Xiang, Dao ; Wang, Min-Jun ; Cai, Yong-Chao ; Zhao, Qing-Hui ; Borjigin, Uyunbilig ; Liu, Wei ; Xiong, Wu-Jun ; Wangensteen, Kirk J. ; Wang, Xin ; Liu, Zhong-Min ; He, Zhi-Ying</creator><creatorcontrib>Wang, Chao ; Chen, Wen-Jian ; Wu, Ying-Fu ; You, Pu ; Zheng, Shang-Yong ; Liu, Chang-Cheng ; Xiang, Dao ; Wang, Min-Jun ; Cai, Yong-Chao ; Zhao, Qing-Hui ; Borjigin, Uyunbilig ; Liu, Wei ; Xiong, Wu-Jun ; Wangensteen, Kirk J. ; Wang, Xin ; Liu, Zhong-Min ; He, Zhi-Ying</creatorcontrib><description>It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC.</description><identifier>ISSN: 2041-4889</identifier><identifier>EISSN: 2041-4889</identifier><identifier>DOI: 10.1038/s41419-018-0622-x</identifier><identifier>PMID: 29760381</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13 ; 13/2 ; 13/51 ; 45 ; 45/91 ; 64 ; 64/60 ; Antibodies ; Bile ; Biochemistry ; Biomedical and Life Sciences ; Carcinogenesis ; Cell Biology ; Cell Culture ; Cell fate ; Hepatocellular carcinoma ; Hepatocytes ; Immunology ; Immunosurveillance ; Life Sciences ; Liver ; Liver cancer ; Macrophages ; Senescence</subject><ispartof>Cell death & disease, 2018-05, Vol.9 (5), p.575-14, Article 575</ispartof><rights>The Author(s) 2018</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-716947cb7cc7e31135218647bb0f43959bc55016aa332e9e007855532da163e3</citedby><cites>FETCH-LOGICAL-c400t-716947cb7cc7e31135218647bb0f43959bc55016aa332e9e007855532da163e3</cites><orcidid>0000-0002-0087-2277</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951829/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951829/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29760381$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Chao</creatorcontrib><creatorcontrib>Chen, Wen-Jian</creatorcontrib><creatorcontrib>Wu, Ying-Fu</creatorcontrib><creatorcontrib>You, Pu</creatorcontrib><creatorcontrib>Zheng, Shang-Yong</creatorcontrib><creatorcontrib>Liu, Chang-Cheng</creatorcontrib><creatorcontrib>Xiang, Dao</creatorcontrib><creatorcontrib>Wang, Min-Jun</creatorcontrib><creatorcontrib>Cai, Yong-Chao</creatorcontrib><creatorcontrib>Zhao, Qing-Hui</creatorcontrib><creatorcontrib>Borjigin, Uyunbilig</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><creatorcontrib>Xiong, Wu-Jun</creatorcontrib><creatorcontrib>Wangensteen, Kirk J.</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Liu, Zhong-Min</creatorcontrib><creatorcontrib>He, Zhi-Ying</creatorcontrib><title>The extent of liver injury determines hepatocyte fate toward senescence or cancer</title><title>Cell death & disease</title><addtitle>Cell Death Dis</addtitle><addtitle>Cell Death Dis</addtitle><description>It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC.</description><subject>13</subject><subject>13/2</subject><subject>13/51</subject><subject>45</subject><subject>45/91</subject><subject>64</subject><subject>64/60</subject><subject>Antibodies</subject><subject>Bile</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Carcinogenesis</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Cell fate</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatocytes</subject><subject>Immunology</subject><subject>Immunosurveillance</subject><subject>Life Sciences</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Macrophages</subject><subject>Senescence</subject><issn>2041-4889</issn><issn>2041-4889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kU9rGzEQxUVJSEKSD5BLEfTSyzb6v6tLoYQmLQRKwXehlWftNeuVI2lT-9t3glMnKUQHaeD95mmGR8gVZ184k811VlxxWzHeVMwIUW0_kDPBFK9U09ijV_Upucx5xfBIyYQ2J-RU2NqgBz8jv2dLoLAtMBYaOzr0j5BoP66mtKNzKJDW_QiZLmHjSwy7ArTzeJX4x6c5zYBigDEAjYkGj0W6IMedHzJcPr_nZHb7fXbzo7r_dffz5tt9FRRjpaq5saoObR1CDZJzqQVvjKrblnVKWm3boDXjxnspBVhgrG601lLMPTcS5Dn5urfdTO0a5jhESX5wm9Svfdq56Hv3Vhn7pVvER6et5o2waPD52SDFhwlycesedxkGP0KcshNMWmGNajSin_5DV3FKI26HlMYcai0MUnxPhRRzTtAdhuHMPUXm9pE5jMw9Rea22PPx9RaHjn8BISD2QEZpXEB6-fp917_A0KGC</recordid><startdate>20180514</startdate><enddate>20180514</enddate><creator>Wang, Chao</creator><creator>Chen, Wen-Jian</creator><creator>Wu, Ying-Fu</creator><creator>You, Pu</creator><creator>Zheng, Shang-Yong</creator><creator>Liu, Chang-Cheng</creator><creator>Xiang, Dao</creator><creator>Wang, Min-Jun</creator><creator>Cai, Yong-Chao</creator><creator>Zhao, Qing-Hui</creator><creator>Borjigin, Uyunbilig</creator><creator>Liu, Wei</creator><creator>Xiong, Wu-Jun</creator><creator>Wangensteen, Kirk J.</creator><creator>Wang, Xin</creator><creator>Liu, Zhong-Min</creator><creator>He, Zhi-Ying</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0087-2277</orcidid></search><sort><creationdate>20180514</creationdate><title>The extent of liver injury determines hepatocyte fate toward senescence or cancer</title><author>Wang, Chao ; Chen, Wen-Jian ; Wu, Ying-Fu ; You, Pu ; Zheng, Shang-Yong ; Liu, Chang-Cheng ; Xiang, Dao ; Wang, Min-Jun ; Cai, Yong-Chao ; Zhao, Qing-Hui ; Borjigin, Uyunbilig ; Liu, Wei ; Xiong, Wu-Jun ; Wangensteen, Kirk J. ; Wang, Xin ; Liu, Zhong-Min ; He, Zhi-Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-716947cb7cc7e31135218647bb0f43959bc55016aa332e9e007855532da163e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>13</topic><topic>13/2</topic><topic>13/51</topic><topic>45</topic><topic>45/91</topic><topic>64</topic><topic>64/60</topic><topic>Antibodies</topic><topic>Bile</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Carcinogenesis</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Cell fate</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatocytes</topic><topic>Immunology</topic><topic>Immunosurveillance</topic><topic>Life Sciences</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Macrophages</topic><topic>Senescence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Chao</creatorcontrib><creatorcontrib>Chen, Wen-Jian</creatorcontrib><creatorcontrib>Wu, Ying-Fu</creatorcontrib><creatorcontrib>You, Pu</creatorcontrib><creatorcontrib>Zheng, Shang-Yong</creatorcontrib><creatorcontrib>Liu, Chang-Cheng</creatorcontrib><creatorcontrib>Xiang, Dao</creatorcontrib><creatorcontrib>Wang, Min-Jun</creatorcontrib><creatorcontrib>Cai, Yong-Chao</creatorcontrib><creatorcontrib>Zhao, Qing-Hui</creatorcontrib><creatorcontrib>Borjigin, Uyunbilig</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><creatorcontrib>Xiong, Wu-Jun</creatorcontrib><creatorcontrib>Wangensteen, Kirk J.</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Liu, Zhong-Min</creatorcontrib><creatorcontrib>He, Zhi-Ying</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell death & disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Chao</au><au>Chen, Wen-Jian</au><au>Wu, Ying-Fu</au><au>You, Pu</au><au>Zheng, Shang-Yong</au><au>Liu, Chang-Cheng</au><au>Xiang, Dao</au><au>Wang, Min-Jun</au><au>Cai, Yong-Chao</au><au>Zhao, Qing-Hui</au><au>Borjigin, Uyunbilig</au><au>Liu, Wei</au><au>Xiong, Wu-Jun</au><au>Wangensteen, Kirk J.</au><au>Wang, Xin</au><au>Liu, Zhong-Min</au><au>He, Zhi-Ying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The extent of liver injury determines hepatocyte fate toward senescence or cancer</atitle><jtitle>Cell death & disease</jtitle><stitle>Cell Death Dis</stitle><addtitle>Cell Death Dis</addtitle><date>2018-05-14</date><risdate>2018</risdate><volume>9</volume><issue>5</issue><spage>575</spage><epage>14</epage><pages>575-14</pages><artnum>575</artnum><issn>2041-4889</issn><eissn>2041-4889</eissn><abstract>It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>29760381</pmid><doi>10.1038/s41419-018-0622-x</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-0087-2277</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2041-4889 |
ispartof | Cell death & disease, 2018-05, Vol.9 (5), p.575-14, Article 575 |
issn | 2041-4889 2041-4889 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5951829 |
source | DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | 13 13/2 13/51 45 45/91 64 64/60 Antibodies Bile Biochemistry Biomedical and Life Sciences Carcinogenesis Cell Biology Cell Culture Cell fate Hepatocellular carcinoma Hepatocytes Immunology Immunosurveillance Life Sciences Liver Liver cancer Macrophages Senescence |
title | The extent of liver injury determines hepatocyte fate toward senescence or cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A23%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20extent%20of%20liver%20injury%20determines%20hepatocyte%20fate%20toward%20senescence%20or%20cancer&rft.jtitle=Cell%20death%20&%20disease&rft.au=Wang,%20Chao&rft.date=2018-05-14&rft.volume=9&rft.issue=5&rft.spage=575&rft.epage=14&rft.pages=575-14&rft.artnum=575&rft.issn=2041-4889&rft.eissn=2041-4889&rft_id=info:doi/10.1038/s41419-018-0622-x&rft_dat=%3Cproquest_pubme%3E2054147526%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2054147526&rft_id=info:pmid/29760381&rfr_iscdi=true |